If you haven’t heard Snap, better known as Snapchat, is being investigated for its disclosures leading up to its IPO in 2017. You can find a good overview at TheStreet about the ins and outs of the case, but here are the two major allegations: Snap withheld information regarding the level of competition it faced … Continue reading D&O Lessons From Snapchat
There is a lot of news recently that relates to D&O insurance recently and I thought I would do a quick run-down for you. First we have Tesla and Elon Musk. If you haven’t seen or heard, Musk and Tesla were each fined $20 million for Musk’s tweet saying they were going private and that … Continue reading Tesla, Harvey Weinstein, and Board Composition for California Companies – A Review of News that Could Impact the D&O Market
Each week, I take a common question I get from clients and prospects about insurance and answer it. If you have a question you would like me to answer please feel free to shoot me an email at email@example.com. The question today is – “Why do I need Directors & Officers (D&O) insurance?” A similar … Continue reading Common Question Friday – Why Do I Need D&O Insurance?
One of the most common questions I get asked comes from Pre-Clinical Life Science companies is why do I need insurance? I agree that pre-clinical life science companies have about as little risk as a company can have. Why they need insurance really comes down to contracts, investors and statutory regulations. If the company enters … Continue reading Common Question Friday – Why Do Pre-Clinical Companies Need Insurance?
Directors & Officers liability has been a popular topic as of late for me. Every day there are new headlines and the one that could have the biggest impact would be the recent story about shareholders losing their right to sue corporations. The headline came from The Intercept and was titled, “Will Shareholders Lose the … Continue reading Arbitration or Shareholder Suits – Would a Change Lower your D&O Premium?
Last week the issue of public companies having to do quarterly reports popped up in the news in a big way with the President tweeting and then speaking on the possibility of ending quarterly reporting. There are a lot of opinions out there on whether this is a good idea or bad idea. Some people … Continue reading How Changing the Reporting Period for Public Companies to Semiannual Could Impact the D&O Market
Cornerstone Research always puts out great data and this report on Securities Class Action Filings for the first half of 2018 is no exception. I recommend you check out the full report which you can find here. These visuals really speak for themselves but the big takeaway is that if you are publicly traded company … Continue reading Why Securities Class Filings are a Reality for Publicly Traded Companies